States Putting More Scrutiny on Patient-Facing AI Use Cases
Lisa Mazur, J.D., head of strategy for law firm McDermott Will & Schulte’s healthcare practice, discusses developments around chatbots, algorithmic fairness, and prior authorization
Read More
First Therapy for Rare Tumor Is a Blockbuster Prospect, But Does Precigen Have the Cash to Make It Happen?
Precigen’s Papzimeos is the first FDA-approved drug for the rare disease recurrent respiratory papillomatosis, or RRP. While this immunotherapy carries blockbuster expectations, Precigen’s financial reports indicate budgetary challenges. The post First Therapy for Rare Tumor Is a Blockbuster Prospect, But Does Precigen Have the Cash to Make It Happen? appeared first on MedCity News.
Employers Press Congress To Cement Health Price Transparency Before Trump’s Return
It seems simple: Require hospitals and insurers to post their negotiated prices for most health care services and — bingo — competition follows, yielding lower costs for consumers. But nearly four years after the first Trump administration’s regulations forced hospitals to post massive amounts of pricing information online, the effect on patients’ costs is unclear….
Expansions to Health Savings Accounts in House Budget Reconciliation: Unpacking the Provisions and Costs to Taxpayers
The House budget reconciliation bill contains various expansions to Health Savings Accounts (HSAs). This policy watch explains what HSAs are, how they have been used, what the key changes to HSAs would be, and how much they would cost the federal government.
New Report: How Consolidation Fuels the Healthcare Affordability Crisis
A handful of corporate hospital systems now dominate most U.S. hospital care, leading to higher prices for consumers
Trump, RFK Jr., and the Healthcare Bombshell No One Sees Coming
The convergence of Trump’s political capital, Kennedy’s agricultural vision, and existing technological capabilities creates an unprecedented opportunity to restructure America’s approach to health and disease prevention. The post Trump, RFK Jr., and the Healthcare Bombshell No One Sees Coming appeared first on MedCity News.
How LG Is Moving Into Clinical Workflows
As it deepens its push into healthcare, LG is developing more tools and workstations aimed at supporting clinical workflows. National sales leader Jim Salamon said the company’s innovations are designed around clinician needs, such as the desire for more lifelike color representation and lightweight displays that can be set up easily for home use. The…
Echoing 2020, Police Use Rubber Bullets Against Protesters in Los Angeles
Weapons dubbed “less lethal” are once again being used in Los Angeles, this time against people protesting the Trump administration’s immigration raids. During the 2020 protests sparked by the police killing of George Floyd, KFF Health News and USA Today documented the harm that rubber bullets and other “less lethal” projectiles can cause. Here’s what…
Sanofi Expands Immunology Prospects, Acquiring Novel Bispecific Drug in $600M Deal
Sanofi is building on its immunology ambitions by acquiring an early clinical Dren Bio drug candidate that offers a potential first-in-class approach to autoimmune disorders such as lupus. It’s the latest acquisition in what has become an active space for dealmaking. The post Sanofi Expands Immunology Prospects, Acquiring Novel Bispecific Drug in $600M Deal appeared…
Expert Care in Houston: Top-Rated Hand and Wrist Surgeons You Can Trust
[Sponsored] Too many people sacrifice their quality of life by putting off a surgical procedure. Discover the top-rated hand and wrist surgeons in the Houston area who can help. The post Expert Care in Houston: Top-Rated Hand and Wrist Surgeons You Can Trust appeared first on MedCity News.